Bruce Thornton
CIK: 0001383288
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNOA
Sonoma Pharmaceuticals, Inc.
Officer
Discretionary Trading P&L
Holdings
About Thornton Bruce
Thornton Bruce (SEC CIK 0001383288) files insider reports with the SEC as Executive VP & COO of Sonoma Pharmaceuticals, Inc. (SNOA).
Signal8 holds 2 ownership filings by Thornton Bruce, all Form 4s, filed between Jan 3, 2025 and Jun 20, 2025. Those filings report 2 transactions, from Jan 2, 2025 to Jun 19, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Thornton Bruce's filings is in BOULDER, CO.
Recent filings by Thornton Bruce
Other insiders filing for Sonoma Pharmaceuticals, Inc. (SNOA)
- Weigerstorfer Philippe, Director
- Trombly Amy Moss, Chief Executive Officer
- MCLAUGHLIN JOHN, Director
- Jacoby Vanessa, Director
- DVONCH JEROME J, Chief Financial Officer
- Dal Poggetto John, Controller